SR 49
- Session Year: 2019-2020
- House: Senate
- Latest Version Date: 2019-07-01
|
Date
|
Status
|
|---|---|
| Jun 27, 2019 | Read. Adopted. (Ayes 37. Noes 0.) |
| Jun 12, 2019 | From committee: Ordered to third reading. |
| Jun 10, 2019 | Introduced. Referred to Com. on RLS. |
|
Date
|
Description
|
Location
|
Votes
|
|
|---|---|---|---|---|
| Jun 27, 2019 | Senate 3rd Reading SR49 Glazer et al. | Senate Floor |
Passed |
This list shows positions taken on this bill by organizations on the date displayed, which is linked to the original source.
Positions by individuals are not included.
Office of Senate Floor Analyses (916) 651-1520 Fax: (916) 327-4478 | SR 49 |
THIRD READING
Bill No: SR 49
Introduced: 6/10/19
SUBJECT: Non-Small Cell Lung Cancer Awareness Week
DIGEST:
This resolution proclaims the week of June 24, 2019, to June 30, 2019, inclusive, as Non-Small Cell Lung Cancer Awareness Week in the State of California.
ANALYSIS: This resolution makes the following legislative findings:
- Non-small cell lung cancer (NSCLC) is a disease in which malignant (cancer) cells form in the tissues of the lung. It is the most common form of lung cancer and one of two major types of lung cancer.
- Signs of NSCLC include a cough that does not go away and shortness of breath.
- NSCLC can affect both smokers and nonsmokers. However, currently, it mostly affects smokers.
- If NSCLC is localized, there is a 60-percent likelihood that the person will live for at least five years after being diagnosed. However, if NSCLC is discovered later, there is only a six-percent likelihood that the person will live for at least five years. The sooner NSCLC is diagnosed, the greater the likelihood that the person will live longer.
- Currently, promising results exist in immunotherapy for NSCLC for patients who have the matching genomic mutations or driver mutations, and the recent approval of multiple types of immunotherapy is leading to more research on the use of these drugs to help the immune system control NSCLC growth.
- Researchers are also using personalized drug therapy to predict whether a specific drug, such as chemotherapy or targeted therapy, may be effective in fighting the features of lung tumors.
This resolution proclaims the week of June 24, 2019, to June 30, 2019, inclusive, as Non-Small Cell Lung Cancer Awareness Week in the State of California.
FISCAL EFFECT: Appropriation: No Fiscal Com.: No Local: No
Jeanette Fritzky Foundation
OPPOSITION: (Verified 6/12/19)
None received
Prepared by: Karen Chow / SFA / (916) 651-1520
6/12/19 14:00:21
**** END ****
Bill Author
Bill Co-Author(s):